| Literature DB >> 26842271 |
Colman Siu Cheung Fung1, Esther Yee Tak Yu1, Vivian Yawei Guo1, Carlos King Ho Wong1, Kenny Kung1, Sin Yi Ho1, Lai Ying Lam1, Patrick Ip2, Daniel Yee Tak Fong3, David Chi Leung Lam4, William Chi Wai Wong1, Sandra Kit Man Tsang5, Agnes Fung Yee Tiwari3, Cindy Lo Kuen Lam1.
Abstract
INTRODUCTION: People from working poor families are at high risk of poor health partly due to limited healthcare access. Health empowerment, a process by which people can gain greater control over the decisions affecting their lives and health through education and motivation, can be an effective way to enhance health, health-related quality of life (HRQOL), health awareness and health-seeking behaviours of these people. A new cohort study will be launched to explore the potential for a Health Empowerment Programme to enable these families by enhancing their health status and modifying their attitudes towards health-related issues. If proven effective, similar empowerment programme models could be tested and further disseminated in collaborations with healthcare providers and policymakers. METHOD AND ANALYSIS: A prospective cohort study with 200 intervention families will be launched and followed up for 5 years. The following inclusion criteria will be used at the time of recruitment: (1) Having at least one working family member; (2) Having at least one child studying in grades 1-3; and (3) Having a monthly household income that is less than 75% of the median monthly household income of Hong Kong families. The Health Empowerment Programme that will be offered to intervention families will comprise four components: health assessment, health literacy, self-care enablement and health ambassador. Their health status, HRQOL, lifestyle and health service utilisation will be assessed and compared with 200 control families with matching characteristics but will not receive the health empowerment intervention. ETHICS AND DISSEMINATION: This project was approved by the University of Hong Kong-the Hospital Authority Hong Kong West Cluster IRB, Reference number: UW 12-517. The study findings will be disseminated through a series of peer-reviewed publications and conference presentations, as well as a yearly report to the philanthropic funding body-Kerry Group Kuok Foundation (Hong Kong) Limited. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/Entities:
Keywords: PREVENTIVE MEDICINE; PRIMARY CARE; PUBLIC HEALTH
Mesh:
Year: 2016 PMID: 26842271 PMCID: PMC4746471 DOI: 10.1136/bmjopen-2015-010015
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Map of Hong Kong showing the location of Tung Chung and location of available healthcare services for Tung Chung residents. According to the 2011 census, around 78 000 residents were living in Tung Chung new town. To satisfy the shelter demands, three public housing estates, Fu Tung Estate, Yat Tung (I) Estate and Yat Tung (II) Estate, have been established to provide more than 13 000 residential units to Tung Chung residents. However, since it is located on the north-western coast of Lantau Island in Hong Kong, a minimum of 45 minutes travelling time using the Mass Transit Railway (MTR) metro system is required for residents to travel to Hong Kong's business centre in Central, other commercial centres or the nearest regional hospital with full medical services (the Princess Margaret Hospital). (The map was drawn using the software R V.3.1.1.).
Figure 2Cohort study design and participant flows.
Health parameter measurements at baseline and follow-up for intervention and control groups.
| Baseline* | Follow-up* | |||
|---|---|---|---|---|
| Intervention | Control | Intervention | Control | |
| 1. Telephone health survey | ||||
| Empowerment, quality of life and well-being† | ||||
| PEI | × | × | × | × |
| SF-12v2 | × | × | × | × |
| DASS | × | × | ||
| GSE | × | × | ||
| GRS | × | × | × | × |
| Socioeconomic status† | ||||
| Marital status | × | × | ||
| Education background | × | × | ||
| Occupation | × | × | ||
| Monthly household income | × | × | × | × |
| Health service utilisation | ||||
| Having a family doctor | × | × | × | × |
| Doctor consultation | × | × | × | × |
| Emergency department attendance and hospital admission | × | × | × | × |
| 2. Clinical assessment | ||||
| Health questionnaire | ||||
| Physical activity (IPAQ-short form) | × | × | × | × |
| Smoking status | × | × | × | × |
| Alcohol consumption | × | × | × | × |
| Illicit substance use | × | × | × | × |
| Medical history | ||||
| History of drug allergy | × | × | × | × |
| Current medication | × | × | × | × |
| Immunisation record | × | × | × | × |
| Previous use of health tests | × | × | × | × |
| Medical history | × | × | × | × |
| Family history of possible hereditary disease | × | × | ||
| Lower urinary tract symptoms (IPSS and ICIQ UI SF)† | × | × | × | × |
| Depression (PHQ-9)‡ | × | × | × | × |
| Domestic violence (AAS-5†/AAS-2§) | × | × | × | × |
| Physical assessments | ||||
| Anthropometric measurement | ||||
| Weight and height | × | × | × | × |
| Waist circumference and hip circumference | × | × | × | × |
| Blood pressure and pulse | × | × | × | × |
| Vision | ||||
| Hyperopia/myopia | × | × | × | × |
| Colour blindness (Ishihara Colour Vision Test) | × | × | ||
| Strabismus (Hirschberg test)§ | × | × | ||
| Macular degeneration (Amsler grid test)† | × | × | × | × |
| Hearing | ||||
| PTA | × | × | × | × |
| Rinne test | × | × | × | × |
| Weber's test | × | × | × | × |
| Oral health | × | × | × | × |
| Spirometry | × | × | × | × |
| Elderly mobility (TUG)¶ | × | × | × | × |
| Cognitive assessments | ||||
| Intellectual ability (WISC-IV-HK-SF)** | × | × | ||
| Behaviour and psychosocial well-being (SDQ and CHQ-50)** | × | × | ||
| Dementia (AMT)¶ | × | × | × | × |
| Laboratory measures† | ||||
| Fasting blood glucose | × | × | × | × |
| Lipid profile (total cholesterol, HDL and LDL cholesterol, triglyceride) | × | × | × | × |
| Liver function (total bilirubin, ALT, AST, alkaline phosphatase) | × | × | × | × |
| Kidney function (urea, creatinine, potassium, sodium) | × | × | × | × |
| HBs antigen | × | × | × | × |
| Haematology profile (WCC, RBC, haemoglobin, PCV, platelets, MCV, MCH, MCHC) | × | × | × | × |
| Differential count (neutrophil, lymphocyte, monocyte, eosinophil, basophil, peripheral blood film) | × | × | × | × |
*The assessments will be carried out annually in the intervention group, but only at baseline and at the end of the study for controls.
†Only apply to participants aged over 18 years.
‡Only apply to participants aged over 14 years.
§Only apply to participants aged under 18 years.
¶Only apply to participants aged over 65 years.
**Only apply to children studying in grades 1–3.
AAS, Abuse Assessment Screen; ALT, alanine aminotransferase; AMT, Abbreviated mental test; AST, aspartate aminotransferase; CHQ, Child Health Questionnaire; DASS, Depression Anxiety Stress Scales; GRS, Global Rating Scales; GSE, General self-efficacy; HDL, high-density lipoprotein; ICIQ UI SF, the International Consultation on Incontinence Questionnaire urinary incontinence short form; IPAQ, International Physical Activity Questionnaire; IPSS, International Prostate Symptom Score; LDL, low-density lipoprotein; MCH, mean cell haemoglobin; MCHC, mean cell haemoglobin concentration; MCV, mean cell volume; PCV, packed cell volume; PEI, patient enablement instrument; PHQ, Patient Health Questionnaire; PTA, Pure tone audiogram; RBC, red blood cell; SDQ, Strengths and Difficulties Questionnaire; SF-12v2, Short-Form Health Survey—the second version; TUG, Timed up and go; WCC, White cell count; WISC-IV-HK-SF, Wechsler Intelligence Scale for Children—Hong Kong (Short Form).
Participant-reported outcome measurements used in Self-care Enablement Programme
| Post-programme | ||||
|---|---|---|---|---|
| Immediate effect | Short-term effect | Long-term effect | ||
| Time point | Pre-programme | Immediately after | 3 months after | 12 months after |
| Measurements | SF-12v2 | SF-12v2 | SF-12v2 | SF-12v2 |
GRS, Global Rating Scale; PEI, Patient Enablement Instrument; SF-12v2, Short-Form Health Survey—the second version.